web analytics
Dave Barnes, Ph.D. founder, CEO, CSO of Velesco Pharmaceutical Services

Dave Barnes, Ph.D. - CEO/CSO

Scientific Leadership


David Barnes, Ph.D.

David Barnes, Ph.D., founder and CEO/CSO of Velesco Pharmaceutical Services

Dave Barnes is a founder, chief executive officer, and chief scientific officer of Velesco Pharmaceutical Services. Dave worked for Pfizer for 19 years in the Pharmaceutical Sciences Division of Research & Development. He is an accomplished scientist with broad expertise in drug formulation, drug product development, GMP manufacturing, clinical supply provision and facility management. He has extensive experience in managing complex scientific and technical drug development projects, many of them outsourced to contract research organizations (CRO).


With his broad depth of experience in drug formulation ranging from early phase non-clinical drug products through the development and transfer of commercial dosage forms into pharmaceutical manufacturing production facilities, Dave is recognized as a technical expert in his field, having written several papers and given many technical presentations at international conferences and symposiums.  He ensures that he is involved in the scientific oversight of the projects undertaken by Velesco.


Dave has a Pharmacy degree and Ph.D. in Pharmaceutical Sciences from The School of Pharmacy, University of London.

News and Events

Pace® Life Sciences Acquires Velesco Pharmaceutical Services, Expanding Capabilities in Drug Development Services

Read the Press Release!

Dave Barnes, Ph.D. CEO/CSO is a featured speaker for the webinar Topical Formulation: Selection of Excipients and Better Process Understanding for Success in Commercial Manufacturing. Webinar recording available now.

View Recording!

Newly Acquired DEA Analytical Laboratory License. We are licensed to use schedules 2, 2N, 3, 3N, 4, and 5.

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services.

Roundtable: M&A trends in CDMO - Molecule to Market

New Velesco Pharma clinical manufacturing facility begins operations.

Read the press release here.

Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing.

Read the interview here.

Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group.

Read the press release here.

CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing!

1 new job postings! Careers

Velesco's work published

Formulation Development & Manufacturing:
Using a Single Provider Reduces Costs & Risk
Read it here.

Follow Velesco

LinkedIn IN Icon 25px Google+ Follow VelescoPharma on Twitter FB FindUsOnFacebook 100